Taiyen Biotech Co Ltd Cash Flow Reinvestment Rate
Taiyen Biotech Co Ltd cash flow reinvestment rate. Taiyen Biotech Co Ltd (1737) has a Cash Flow Reinvestment Rate of 0.42x as of June 2026, reinvesting NT$41.91 Million (capex NT$38.03 Million plus investments NT$3.88 Million) from operating cash flow of NT$99.80 Million. Explore Taiyen Biotech Co Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Taiyen Biotech Co Ltd (2003–2025)
Cash flow reinvestment rate of Taiyen Biotech Co Ltd from 2003 to 2025. Historical reinvestment intensity for Taiyen Biotech Co Ltd across 23 annual periods. Explore Taiyen Biotech Co Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Taiyen Biotech Co Ltd Cash Flow Reinvestment Rate by Year (2003–2025)
Taiyen Biotech Co Ltd cash flow reinvestment rate by year from 2003 to 2025. Year-by-year capital reinvestment analysis for Taiyen Biotech Co Ltd. For the full cash flow conversion analysis, see 1737 cash flow metrics.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.69x | NT$328.17 Million | NT$473.77 Million | NT$300.16 Million | ▲ +42.1% |
| 2024 | 0.49x | NT$321.68 Million | NT$660.12 Million | NT$307.61 Million | ▼ -67.6% |
| 2023 | 1.51x | NT$684.43 Million | NT$454.54 Million | NT$345.13 Million | ▲ +252.8% |
| 2022 | 0.43x | NT$247.87 Million | NT$580.69 Million | NT$246.60 Million | ▼ -39.0% |
| 2021 | 0.70x | NT$419.61 Million | NT$600.08 Million | NT$390.81 Million | ▼ -11.8% |
| 2020 | 0.79x | NT$269.06 Million | NT$339.36 Million | NT$267.89 Million | ▼ -36.3% |
| 2019 | 1.24x | NT$411.65 Million | NT$330.81 Million | NT$284.25 Million | ▲ +63.1% |
| 2018 | 0.76x | NT$343.19 Million | NT$449.83 Million | NT$298.49 Million | ▼ -16.0% |
| 2017 | 0.91x | NT$551.88 Million | NT$607.87 Million | NT$369.68 Million | ▲ +6.9% |
| 2016 | 0.85x | NT$482.65 Million | NT$568.06 Million | NT$190.30 Million | ▲ +130.0% |
| 2015 | 0.37x | NT$141.84 Million | NT$383.93 Million | NT$106.57 Million | ▼ -54.5% |
| 2014 | 0.81x | NT$300.97 Million | NT$371.06 Million | NT$148.81 Million | ▼ -34.1% |
| 2013 | 1.23x | NT$250.23 Million | NT$203.21 Million | NT$93.53 Million | ▲ +73.8% |
| 2012 | 0.71x | NT$109.40 Million | NT$154.46 Million | NT$109.40 Million | ▲ +126.8% |
| 2011 | 0.31x | NT$76.85 Million | NT$246.09 Million | NT$76.85 Million | ▼ -25.5% |
| 2010 | 0.42x | NT$126.08 Million | NT$300.89 Million | NT$126.08 Million | ▲ +30.8% |
| 2009 | 0.32x | NT$114.67 Million | NT$358.02 Million | NT$114.67 Million | ▼ -30.4% |
| 2008 | 0.46x | NT$192.08 Million | NT$417.51 Million | NT$192.08 Million | ▲ +86.2% |
| 2007 | 0.25x | NT$79.70 Million | NT$322.49 Million | NT$79.70 Million | ▼ -22.9% |
| 2006 | 0.32x | NT$148.45 Million | NT$462.88 Million | NT$148.45 Million | ▲ +43.0% |
| 2005 | 0.22x | NT$129.19 Million | NT$575.91 Million | NT$129.19 Million | ▲ +229.6% |
| 2004 | 0.07x | NT$192.93 Million | NT$2.84 Billion | NT$192.93 Million | ▲ +146.5% |
| 2003 | 0.03x | NT$94.39 Million | NT$3.42 Billion | NT$94.39 Million | — |